SymbioFCell has decided to increase its capital in order to finance product industrialization and business development; Michelin has taken a significant minority stake in SymbioFCell. Michelin hence joins shareholders in this capital increase, including the founders, managers and several investment funds: IPSA and CEA Investments (through the CEA strategic fund and its ATI seed-stage fund). […]

